Exploring structure-directed immunogenic cytotoxicity of arginine-rich peptides for cytolysis-induced immunotherapy of cancer DOI
Liu Huang, Ang Li,

Han-jie Liu

et al.

Bioorganic & Medicinal Chemistry, Journal Year: 2024, Volume and Issue: 116, P. 117984 - 117984

Published: Nov. 8, 2024

Language: Английский

Covalent conjugation and non-covalent complexation strategies for intracellular delivery of proteins using cell-penetrating peptides DOI Open Access

Yasaman Behzadipour,

Shiva Hemmati

Biomedicine & Pharmacotherapy, Journal Year: 2024, Volume and Issue: 176, P. 116910 - 116910

Published: June 8, 2024

Therapeutic proteins provided new opportunities for patients and high sales volumes. However, they are formulated extracellular targets. The lipophilic barrier of the plasma membrane renders vast array intracellular targets out reach. Peptide-based delivery systems, namely cell-penetrating peptides (CPPs), have few safety concerns, low immunogenicity, with control over administered doses. This study investigates CPP-based protein systems by classifying them into CPP-protein "covalent conjugation" CPP: "non-covalent complexation" categories. Covalent conjugates ensure proximity CPP to cargo, which can improve cellular uptake endosomal escape. We will discuss various aspects covalent through non-cleavable (stable) or cleavable bonds. Non-cleavable produced recombinant DNA technology express complete fusion in a host cell chemical ligation protein, ensures stability during process. bonds classified pH-sensitive redox-sensitive bonds, enzyme-cleavable physical stimuli linkers (light radiation, ultrasonic waves, thermo-responsive). highlighted key characteristics non-covalent complexes electrostatic hydrophobic interactions preserve conformational integrity cargo. CPP-mediated complexation, such as zippers, adaptor methods, avidin-biotin technology, featured. Conclusively, complexation methods appropriate when number samples be screened. In contrast, biological activity is critical compartment, conjugation protocols preferred.

Language: Английский

Citations

12

Inclusive Pattern Generation Protocols to Decode Thiol-Mediated Uptake DOI Creative Commons

Saidbakhrom Saidjalolov,

Filipe Coelho, Vincent Mercier

et al.

ACS Central Science, Journal Year: 2024, Volume and Issue: 10(5), P. 1033 - 1043

Published: April 17, 2024

Thiol-mediated uptake (TMU) is an intriguing enigma in current chemistry and biology. While the appearance of cell-penetrating activity upon attachment cascade exchangers (CAXs) has been observed by many increasingly being used practice, molecular basis TMU essentially unknown. The objective this study was to develop a general protocol decode dynamic covalent networks that presumably account for TMU. Uptake inhibition patterns obtained from removal exchange partners either protein knockdown or alternative inhibitors are aligned with original generated CAX transporters functions (here cell motility). These inclusive reveal four most significant CAXs known today enter cells along three almost orthogonal pathways. Epidithiodiketopiperazines (ETP) preferably integrins disulfide isomerases (PDIs), benzopolysulfanes (BPS) different PDIs, PDIA3, asparagusic acid (AspA), antisense oligonucleotide phosphorothioates (OPS) transferrin receptor can be activated PDIs their respective inhibitors. findings provide solid understand use enable prevent entry into cells.

Language: Английский

Citations

8

E3MPH16: An efficient endosomolytic peptide for intracellular protein delivery DOI
Yoshimasa Kawaguchi, Yuki Kawamura, H. Hirose

et al.

Journal of Controlled Release, Journal Year: 2024, Volume and Issue: 367, P. 877 - 891

Published: Feb. 20, 2024

Language: Английский

Citations

6

Protein-Based Degraders: From Chemical Biology Tools to Neo-Therapeutics DOI

Lisha Ou,

Mekedlawit Setegne,

Jeandele Elliot

et al.

Chemical Reviews, Journal Year: 2025, Volume and Issue: unknown

Published: Jan. 17, 2025

The nascent field of targeted protein degradation (TPD) could revolutionize biomedicine due to the ability degrader molecules selectively modulate disease-relevant proteins. A key limitation broad application TPD is its dependence on small-molecule ligands target proteins interest. This leaves unstructured or those lacking defined cavities for binding out scope many technologies. use proteins, peptides, and nucleic acids (otherwise known as "biologics") protein-targeting moieties in degraders addresses this limitation. In following sections, we provide a comprehensive critical review studies that have used peptides mediate hence functional control otherwise challenging targets. We describe existing platforms protein/peptide-based ligand identification drug delivery systems might be exploited biologic-based degraders. Throughout Review, underscore successes, challenges, opportunities using protein-based chemical biology tools spur discoveries, elucidate mechanisms, act new therapeutic modality.

Language: Английский

Citations

0

Engineering Cell-Specific Protein Delivery Vehicles for Erythroid Lineage Cells DOI Creative Commons
Mekedlawit Setegne,

Aidan T. Cabral,

Anushri Tiwari

et al.

ACS Bio & Med Chem Au, Journal Year: 2025, Volume and Issue: 5(2), P. 268 - 282

Published: Feb. 27, 2025

Biologics such as proteins, peptides, and oligonucleotides are powerful ligands to modulate challenging drug targets that lack readily accessible "ligandable" pockets. However, the limited membrane permeance of biologics severely restricts their intracellular applications. Moreover, different cell types may exhibit varying levels impermeability, some delivery vehicles might be more sensitive this variance. Erythroid lineage cells especially deliver cargo because unique cytoskeleton absence endocytosis in mature erythrocytes. We recently employed a permeant miniature protein bioPROTACs human umbilical cord blood derived erythroid progenitor (HUDEP-2) primary hematopoietic stem (CD34+) (Shen et al., ACS Cent. Sci. 2022, 8, 1695−1703). While successful, low efficiency cell-type specificity limit use vivo. In work, we thoroughly evaluated performance various reported penetrating peptides (CPPs), CPP additives, bacterial toxins, contractile injection systems for ability precursor cells. also explored how targeting receptors enriched on surface improve efficiencies specificities these vehicles. Our results reveal certain improved when directed while others do not benefit from strategy. Together, findings advance our understanding illustrate intricacies cell-surface receptor targeting.

Language: Английский

Citations

0

In situ peptide assembly for cell membrane rewiring in tumor therapy DOI
Yu Ma, Qiaochu Jiang, Xiaoyang Liu

et al.

Journal of Controlled Release, Journal Year: 2025, Volume and Issue: unknown, P. 113637 - 113637

Published: March 1, 2025

Language: Английский

Citations

0

Rigid nanoparticles for efficient tumor immunotherapy through mechanical force mediated reprogramming of tumor-associated macrophages DOI
Zhihuang Zhang,

Yan Peng,

Liyan Qiu

et al.

Chemical Engineering Journal, Journal Year: 2024, Volume and Issue: 491, P. 152129 - 152129

Published: May 10, 2024

Language: Английский

Citations

3

Finding ways into the cytosol: Peptide-mediated approaches for delivering proteins into cells DOI
Yoshimasa Kawaguchi, Shiroh Futaki

Current Opinion in Chemical Biology, Journal Year: 2024, Volume and Issue: 81, P. 102482 - 102482

Published: June 20, 2024

Language: Английский

Citations

3

The microtubule-dynamin binding inhibitor peptide PHDP5 rescues spatial learning and memory deficits in Alzheimer’s disease model mice DOI Creative Commons
Chia-Jung Chang, Zacharie Taoufiq, Hiroshi Yamada

et al.

Brain Research, Journal Year: 2024, Volume and Issue: 1838, P. 148987 - 148987

Published: May 6, 2024

Dynamin is a microtubule (MT) binding protein playing key role in vesicle endocytosis. In brain slice model, tau loaded presynaptic terminals assembles MTs, thereby impairing endocytosis via depletion of cytosolic dynamin. The peptide PHDP5, derived from the pleckstrin homology domain dynamin 1, inhibits dynamin-MT interaction and rescues synaptic transmission impaired by when co-loaded terminals. We tested whether vivo administration PHDP5 could rescue their learning/memory deficits observed Alzheimer's disease (AD) model mice. A modified incorporating cell-penetrating (CPP) FITC fluorescent marker was delivered intranasally to Tau609 transgenic (Tg) 3xTg-AD FITC-positive puncta were hippocampus mice infused with or scrambled (SPHDP5) peptide, but not saline-infused controls. Morris water maze (MWM) test for spatial learning/memory, AD treated FITC-PHDP5-CPP showed prominent improvements learning memory, performing close level WT control. contrast, construct (FITC-SPHDP5-CPP) no significant improvement. conclude that can be candidate human therapy.

Language: Английский

Citations

1

Strength in numbers: cell penetrating peptide clusters to build next-generation therapeutics DOI
Joseph Reeman, Lars M. Ittner, Katherine A. Vallis

et al.

Trends in Chemistry, Journal Year: 2024, Volume and Issue: unknown

Published: Oct. 1, 2024

Language: Английский

Citations

1